OTS167 Inhibits FLT3 Expression in FLT3 Mutant Acute Myeloid Leukemia

被引：0
|
作者：
Eisfelder, Bartholomew [1 ]
Wynne, Joseph [1 ]
Colton, Margert [1 ]
Cheng, Jason [2 ]
Odenike, Olatoyosi [1 ]
Alachkar, Houda [3 ]
Stock, Wendy [1 ]
机构：
[1] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Pathol, Hematopathol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA
[3] Univ Southern Calif, Sch Pharm, Dept Clin Pharm & Pharmaceut Econ & Policy, Los Angeles, CA USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷
关键词：
FLT3; FLT3-ITD; MELK; OTS167; eIF4B; AML; acute myeloid leukemia;
D O I：
10.1016/j.clml.2019.07.133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-388
引用
收藏
页码：S239 / S240
页数：2
相关论文
共 50 条
  • [21] FLT3 mutational analysis in acute myeloid leukemia
    Gari, Mamdooh
    Abuzenadah, Adel
    Chaudhary, Adeel
    Qahtani, Mohammed
    Al-Sayes, Fatin
    Damanhouri, Ghazi
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 106 - 106
  • [22] Potential targeting of FLT3 acute myeloid leukemia
    Ambinder, Alexander J.
    Levis, Mark
    HAEMATOLOGICA, 2021, 106 (03) : 671 - 681
  • [23] Targeting FLT3 Mutations in Acute Myeloid Leukemia
    El Fakih, Riad
    Rasheed, Walid
    Hawsawi, Yousef
    Alsermani, Maamoun
    Hassanein, Mona
    CELLS, 2018, 7 (01)
  • [24] Importance of PTM of FLT3 in acute myeloid leukemia
    Liu, Jianwei
    Gu, Jianguo
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2024, 56 (08) : 1199 - 1207
  • [25] A review of FLT3 inhibitors in acute myeloid leukemia
    Zhao, Jennifer C.
    Agarwal, Sonal
    Ahmad, Hiba
    Amin, Kejal
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    BLOOD REVIEWS, 2022, 52
  • [26] FLT3 Inhibitors in the Management of Acute Myeloid Leukemia
    Zappone, E.
    Defina, M.
    Aprile, L.
    Bartalucci, G.
    Gozzetti, A.
    Bocchia, M.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (08) : 1028 - 1032
  • [27] The Development of FLT3 Inhibitors in Acute Myeloid Leukemia
    Garcia, Jacqueline S.
    Stone, Richard M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (04) : 663 - +
  • [28] FLT3 Ligand-DM1 Conjugate Selectively Targets Acute Myeloid Leukemia Cells with FLT3 Expression
    Zhang, Dengyang
    Guo, Yao
    Zhao, Yuming
    Yu, Liuting
    Chang, Zhiguang
    Pei, Han Zhong
    Huang, Junbin
    Chen, Chun
    Xue, Hongman
    Pan, Yihang
    Li, Ningning
    Zhu, Chengming
    Zhao, Zhizhuang Joe
    Yu, Jian
    Chen, Yun
    BLOOD, 2020, 136
  • [29] Glucocorticoids enhance the antileukemic activity of FLT3 inhibitors in FLT3-mutant acute myeloid leukemia
    Gebru, Melat T.
    Atkinson, Jennifer M.
    Young, Megan M.
    Zhang, Lijun
    Tang, Zhenyuan
    Liu, Zhenqiu
    Lu, Pinyi
    Dower, Christopher M.
    Chen, Longgui
    Annageldiyev, Charyguly
    Sharma, Arati
    Kawasawa, Yuka Imamura
    Zhao, Zhongming
    Miller, Barbara A.
    Claxton, David F.
    Wang, Hong-Gang
    BLOOD, 2020, 136 (09) : 1067 - 1079
  • [30] Detailed analysis of FLT3 expression levels in acute myeloid leukemia
    Kuchenbauer, Florian
    Kern, Wolfgang
    Schoch, Claudia
    Kohlmann, Alexander
    Hiddemann, Wolfgang
    Haferlach, Torsten
    Schnittger, Susanne
    HAEMATOLOGICA, 2005, 90 (12) : 1617 - 1625
12345